SIBN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
SI-BONE Inc is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive growth potential and hedge funds are buying, the financial performance shows declining profitability, and technical indicators suggest no clear upward momentum. Additionally, there are no significant recent news catalysts or strong trading signals to justify immediate action.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 40.721, and moving averages are converging, showing no clear trend. Key support is at 12.857, and resistance is at 14.645. The stock is currently trading pre-market at 13.65, slightly below the pivot point of 13.751.
Hedge funds are significantly increasing their positions, with a 457520.97% increase in buying over the last quarter. Analysts maintain a Buy rating with a premium multiple justified by faster top-line growth, above-average gross margins, and improving profitability outlook.
The company's net income and EPS have significantly declined YoY (-63.43% and -63.64%, respectively). Gross margin has slightly dropped, and there are no recent news catalysts or congress trading data to support a bullish case. Additionally, the stock trend analysis suggests a potential decline in the short term.
In Q4 2025, revenue increased by 14.99% YoY to $56.35M. However, net income dropped to -$1.64M (-63.43% YoY), and EPS fell to -0.04 (-63.64% YoY). Gross margin slightly decreased to 79.03% (-0.13% YoY).
Analysts maintain a Buy rating with price targets ranging from $20 to $24. Truist recently lowered its price target to $20 from $24 but emphasized the company's faster top-line growth, above-average gross margins, and improving profitability outlook. TD Cowen also sees multiple growth catalysts and progress toward profitability.
